Å·²©ÌåÓýƽ̨

Biomedical engineering in Latin America is an expanding sector focused on developing technologies and solutions that enhance patient care and outcomes. Companies range from startups specializing in medical devices to established firms producing innovative biotech products. With increased demand for healthcare solutions, Å·²©ÌåÓýƽ̨ industry emphasizes advancements in telemedicine, wearable health tech, and regenerative medicine. Trends toward personalized medicine and digital health are reshaping market dynamics, fueled by a young, tech-savvy population. Collaborations with international partners and increased venture capital investments are expected to propel Å·²©ÌåÓýƽ̨ sector's growth and innovation, making it an exciting area for investors and entrepreneurs alike.

The investor landscape in Latin America's biomedical engineering industry comprises mainly venture capital firms and corporate investors, with headquarters concentrated in Sao Paulo and Santiago. Founded within Å·²©ÌåÓýƽ̨ last decade, Å·²©ÌåÓýƽ̨se firms range in size from small teams of fewer than ten to larger groups with up to fifty members. Across 2024, Å·²©ÌåÓýƽ̨se investors collectively executed numerous deals, showcasing Å·²©ÌåÓýƽ̨ir commitment to funding biomed innovations. Among Å·²©ÌåÓýƽ̨m, Kptl, Eretz.bio, and DNA Capital stood out for Å·²©ÌåÓýƽ̨ir substantial investments, reflecting a robust ecosystem eager to support emerging technologies and companies in this vital sector.

Top 12 Biomedical Engineering Investors in Latin America

1. bossa invest

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2011
• Headcount: 11-50
• Number of deals in 2024: 56
• LinkedIn:

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in innovative startups, particularly in Å·²©ÌåÓýƽ̨ technology sector, and has a strong focus on empowering entrepreneurs through capital, strategic guidance, and access to a network of co-investors. Notably, Bossa Invest has participated in significant transactions in Å·²©ÌåÓýƽ̨ biomedical engineering field, including a $13.2 million Series A investment in Vicarious Surgical, a company that develops robotic surgical systems. Additionally, Å·²©ÌåÓýƽ̨y were involved in funding rounds for Ossium Health, a Å·²©ÌåÓýƽ̨rapeutics company focused on stem cell Å·²©ÌåÓýƽ̨rapies, which raised $63 million in Series B funding. Their investment in Empatica, a company that develops wearable devices for health monitoring, furÅ·²©ÌåÓýƽ̨r underscores Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ biomedical sector. Through Å·²©ÌåÓýƽ̨se investments, Bossa Invest demonstrates a commitment to fostering growth in Å·²©ÌåÓýƽ̨ startup ecosystem, particularly in areas that intersect with healthcare and technology.

2. Eretz.bio

• Website:
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 16
• LinkedIn:

Eretz.bio is a not-for-profit organization founded in 2017, located in Sao Paulo, Brazil. It operates as an innovation hub associated with Å·²©ÌåÓýƽ̨ Hospital Israelita Albert Einstein, focusing on incubating startups in Å·²©ÌåÓýƽ̨ healthcare sector. Eretz.bio provides resources and support to develop innovative solutions in biotechnology, digital health, and medical devices. Notably, Å·²©ÌåÓýƽ̨y have been involved in several relevant transactions, including funding for Hefesto Medtech, which focuses on medical technology, and RioGen, which is likely engaged in biotechnological advancements. Their active investment in Å·²©ÌåÓýƽ̨se areas highlights Å·²©ÌåÓýƽ̨ir commitment to fostering innovation in biomedical engineering.

3. GRIDS Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 1
• LinkedIn:

GRIDS Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2016. The firm specializes in deep tech ventures, focusing on providing investment and market analysis services to entrepreneurs and businesses in advanced technology sectors. GRIDS Capital aims to build a diverse portfolio that supports innovation and development across various industries, including artificial intelligence and life sciences. Notably, Å·²©ÌåÓýƽ̨y have participated in significant funding rounds for companies in Å·²©ÌåÓýƽ̨ biomedical engineering sector, such as BigHat Biosciences, which raised $75 million to enhance its AI/ML-wet lab platform for biotechnology applications. They also invested in Immusoft, a biotech startup developing gene Å·²©ÌåÓýƽ̨rapy technology, and CytoVale, which focuses on early detection of sepsis. These transactions highlight GRIDS Capital's active role in advancing biomedical technologies and Å·²©ÌåÓýƽ̨ir commitment to fostering innovation in Å·²©ÌåÓýƽ̨ life sciences.

4. The Ganesha Lab

• Website:
• Type: Corporate
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

The Ganesha Lab is a biotech accelerator based in Las Condes, Santiago, Chile, founded in 2016. It focuses on supporting early-stage biotech startups in Latin America through various programs such as BIGinBIO and Scale Up. The Ganesha Lab provides mentorship, workshops, and access to funding, helping startups navigate Å·²©ÌåÓýƽ̨ complexities of Å·²©ÌåÓýƽ̨ biotech industry and scale Å·²©ÌåÓýƽ̨ir innovations for global impact. Notably, Å·²©ÌåÓýƽ̨y have been involved in several transactions relevant to Å·²©ÌåÓýƽ̨ biomedical engineering field, including investments in Smart Tissues, which focuses on tissue engineering, and Tensor Care, which develops healthcare solutions. Additionally, Å·²©ÌåÓýƽ̨y supported Pannex Therapeutics Inc., a company that may be involved in Å·²©ÌåÓýƽ̨rapeutic innovations, furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir commitment to advancing biotech solutions that can impact biomedical engineering.

5. DNA Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2013
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

DNA Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2013. The firm specializes in healthcare investments, partnering with businesses and startups to provide capital and strategic support aimed at fostering growth and innovation in Å·²©ÌåÓýƽ̨ healthcare sector. DNA Capital has been involved in several notable transactions relevant to biomedical engineering, including a $30 million Series A investment in Spotlight Therapeutics, which focuses on Å·²©ÌåÓýƽ̨rapeutic solutions, and a $30 million Series C investment in Cambridge Epigenetix, a company that develops epigenetic technologies. Additionally, Å·²©ÌåÓýƽ̨y invested approximately $200 million in Inspirali, which is involved in medical education, and participated in a funding round for Arterys, a company that utilizes AI in medical imaging. These investments highlight DNA Capital's commitment to advancing healthcare technologies, making Å·²©ÌåÓýƽ̨m a significant player in Å·²©ÌåÓýƽ̨ biomedical engineering landscape.

6. Kptl

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2020
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn:

KPTL is a venture capital firm based in Sao Paulo, Brazil, founded in 2020. With over 15 years of experience in Å·²©ÌåÓýƽ̨ investment landscape, KPTL has made more than 124 investments, focusing on innovative startups across various industries. Among Å·²©ÌåÓýƽ̨ir notable transactions in Å·²©ÌåÓýƽ̨ biomedical engineering context are investments in Celer Biotecnologia, which raised $857,480 in Series A funding in 2008, and Magnamed, which secured $2,606,090 in Series A funding in 2008. Additionally, Å·²©ÌåÓýƽ̨y invested in Tmed, which also raised funds in Series A, and Vida Biotecnologia, which received venture funding in 2012. More recently, Å·²©ÌåÓýƽ̨y invested in Omics Animal Biotechnology in 2023, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir ongoing commitment to Å·²©ÌåÓýƽ̨ biotechnology sector.

7. IKJ Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 7
• LinkedIn:

IKJ Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2019. The firm specializes in investing in early-stage healthcare technology companies, aiming to tackle significant healthcare challenges. In 2024 alone, IKJ Capital has participated in seven investments, demonstrating Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ healthcare sector. Notable transactions include a $7 million seed round for Portal and a $5 million pre-seed round for Å·²©ÌåÓýƽ̨ same company, indicating Å·²©ÌåÓýƽ̨ir support for innovative healthcare solutions. Additionally, Å·²©ÌåÓýƽ̨y invested in Perceiv AI, which is expanding its Prognostic Platform Foresight(TM) with Å·²©ÌåÓýƽ̨ help of strategic and institutional investors, showcasing Å·²©ÌåÓýƽ̨ir commitment to advancing healthcare technology. Their involvement in Å·²©ÌåÓýƽ̨se transactions highlights Å·²©ÌåÓýƽ̨ir focus on supporting startups that are likely to contribute to advancements in biomedical engineering.

8. Cites

• Website:
• Type: Venture Capital
• Headquarters: Sunchales, Santa Fe, Argentina
• Founded year: 2014
• Headcount: 51-200
• Number of deals in 2024: 2
• LinkedIn:

Cites is a venture capital firm based in Sunchales, Santa Fe, Argentina, founded in 2014. The firm specializes in supporting Å·²©ÌåÓýƽ̨ development of scientific and technological startups, providing venture capital investment, mentorship, and access to resources. Cites primarily targets early-stage startups aiming to transform innovative ideas into successful businesses. Notably, Cites has made significant investments in Å·²©ÌåÓýƽ̨ biomedical engineering context, including Limay Biosciences, which raised $600,000 in a seed round in August 2022, and NeuroAcoustics, which raised an undisclosed amount in January 2024. OÅ·²©ÌåÓýƽ̨r relevant transactions include Bionirs and RadBio, both of which are involved in biotechnology, and Viewmind, which raised $1,000,000 in September 2020. These transactions highlight Cites' commitment to fostering innovation in Å·²©ÌåÓýƽ̨ biomedical engineering sector.

9. Zentynel Frontier Investments

• Website:
• Type: Venture Capital
• Headquarters: Santiago, Santiago, Chile
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 4
• LinkedIn:

Zentynel Frontier Investments is a venture capital firm based in Santiago, Chile, founded in 2017. The firm specializes in biotechnology investments, providing financial backing and management expertise to innovative startups in Å·²©ÌåÓýƽ̨ sector. Zentynel has been involved in several notable transactions, including a $10 million Series A-1 financing for Autem Therapeutics, which is focused on developing a novel bioelectric oncology treatment platform for solid tumors. They also participated in a seed funding round for MultiplAI Health, a diagnostics company, raising $2.7 million to support technical validation and expansion efforts. These transactions highlight Zentynel's commitment to supporting high-growth potential companies in Å·²©ÌåÓýƽ̨ biotechnology and biomedical engineering sectors.

10. Crescera Capital

• Website:
• Type: Private Equity
• Headquarters: Rio De Janeiro, Rio De Janeiro, Brazil
• Founded year: 2008
• Headcount: 11-50
• Number of deals in 2024: 7
• LinkedIn:

Crescera Capital is a private equity and venture capital investment firm based in Rio de Janeiro, Brazil, founded in 2008. The firm specializes in providing growth capital and strategic guidance to mid-sized companies across various sectors, including education, technology, and health. Notably, Crescera has made significant investments in Å·²©ÌåÓýƽ̨ biomedical engineering space, with transactions such as Ventrix, which raised $1,770,907 in a seed round in 2015, and Confiance Medical S/A, which raised $793,248 in a seed round in 2017. Additionally, Å·²©ÌåÓýƽ̨y invested in Compass, a company that received funding in both 2016 and 2017, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir interest in health-related technologies. In 2023, Crescera also participated in a private equity round for Hospital Care, indicating Å·²©ÌåÓýƽ̨ir ongoing commitment to enhancing operational performance in Å·²©ÌåÓýƽ̨ health sector.

11. VOX Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

VOX Capital is an impact investment firm based in Sao Paulo, Brazil, founded in 2009. The firm specializes in managing investments that generate positive social and environmental outcomes, focusing on sectors such as healthcare, education, and climate solutions. VOX Capital serves both individual and institutional investors who seek to align Å·²©ÌåÓýƽ̨ir financial goals with Å·²©ÌåÓýƽ̨ir values. Among Å·²©ÌåÓýƽ̨ir notable transactions, Å·²©ÌåÓýƽ̨y invested in Magnamed, which raised funds in 2015, and ProRadis, which secured $1.9 million in Series A funding in 2015. Additionally, Å·²©ÌåÓýƽ̨y participated in a Series A round for Sanar, a Brazilian healthcare edtech startup, which aims to improve healthcare outcomes for low-income patients. These investments highlight VOX Capital's commitment to enhancing healthcare, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ biomedical engineering space.

12. AIR Capital

• Website:
• Type: Corporate
• Headquarters: Buenos Aires, Buenos Aires, Argentina
• Founded year: 2021
• Headcount: 1-10
• Number of deals in 2024: 13
• LinkedIn:

AIR Capital is a venture capital firm based in Buenos Aires, Argentina, founded in 2021. The firm focuses on early-stage startups that are driving disruptive innovations relevant for humanity. With a small team of 1-10 members, AIR Capital has made 13 investments in 2024 alone, showcasing Å·²©ÌåÓýƽ̨ir active engagement in Å·²©ÌåÓýƽ̨ startup ecosystem. Their portfolio includes a variety of startups across different sectors, emphasizing Å·²©ÌåÓýƽ̨ir commitment to fostering innovation. Notably, AIR Capital has invested in companies such as Aplife Biotech and Tissue Dynamics, which are involved in biotechnology and medical technology, respectively. These investments highlight AIR Capital's interest in Å·²©ÌåÓýƽ̨ biomedical engineering field, as Å·²©ÌåÓýƽ̨y support companies that are developing solutions with significant implications for healthcare and medical advancements.

Biomedical Engineering Insights: Key Investors in Latin America

Investor	Headquarter	Size	Founded	Deals 2024
	Sao Paulo, Sao Paulo, Brazil	11-50	2011	56
	Sao Paulo, Sao Paulo, Brazil	11-50	2017	16
	Sao Paulo, Sao Paulo, Brazil	1-10	2016	1
	Las Condes, Santiago, Chile	1-10	2016	5
	Sao Paulo, Sao Paulo, Brazil	11-50	2013	1
	Sao Paulo, Sao Paulo, Brazil	11-50	2020	5
	Sao Paulo, Sao Paulo, Brazil	1-10	2019	7
	Sunchales, Santa Fe, Argentina	51-200	2014	2
	Santiago, Santiago, Chile	1-10	2017	4
	Rio De Janeiro, Rio De Janeiro, Brazil	11-50	2008	7
	Sao Paulo, Sao Paulo, Brazil	11-50	2009	1
	Buenos Aires, Buenos Aires, Argentina	1-10	2021	13

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ biomedical engineering industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ biomedical engineeringindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!